"","Num","POD","SD","%","Genes","KE"
"ABNORMAL BLOOD POTASSIUM CONCENTRATION","2","0.00237370470525846","1.54671545272389","16.67","cyp11a1, kcnh2a","INCREASED BLOOD POTASSIUM CONCENTRATION"
"ABNORMAL CIRCULATING CHOLESTEROL CONCENTRATION","2","0.00338983409678172","1.65614146672308","18.18","cyp11a1, pmm2","DECREASED CHOLESTEROL; PERTURBATION OF CHOLESTEROL"
"ABNORMAL BLOOD SODIUM CONCENTRATION","3","0.00342606109400522","0.932779690317855","33.33","cyp11a1, fgfr1a, nfkb2","DECREASED SODIUM CONDUCTANCE 2; DECREASED SODIUM REABSORPTION"
"HEPATOCELLULAR CARCINOMA","2","0.0101859985645883","2.08905452413604","15.38","casp8, igf2b","FORMATION HEPATOCELLULAR AND BILE DUCT TUMORS; INCREASE ADENOMAS/CARCINOMAS HEPATOCELLULAR; TUMORIGENESIS HEPATOCELLULAR CARCINOMA"
"CTOME SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R","3","0.0473912392585125","1.04671698651213","23.08","fgf8a, fgfr1a, igf2b","INCREASED IGF-1 MOUSE"
"G OOCYTE MEIOSIS","6","0.0482627615400613","0.382949065830851","15","calm1b, cdc27, ppp2cb, rbx1, skp1, ywhah","REDUCED MEIOTIC PROPHASE I/METAPHASE I TRANSITION OOCYTE"
"PROSTAGLANDIN SYNTHESIS AND REGULATION","3","0.0599317188976991","1.04443378092302","11.54","cyp11a1, ednraa, ednrba","REDUCTION PROSTAGLANDIN E2 CONCENTRATION; REDUCED PROSTAGLANDIN F2ALPHA CONCENTRATION PLASMA"
"CTOME IKBA VARIANT LEADS TO EDA ID","2","0.0692234155050926","1.45358991831132","50","nfkb1, nfkb2","INDUCTION IKB INHIBITORY PROTEIN"
"ABNORMALITY OF THE PITUITARY GLAND","10","0.0902819461373492","0.233200570160261","20.83","btk, cyp11a1, fgf8a, fgfr1a, gata6, igf2b, nfkb2, pmm2, polr3h, srp54","INCREASED ADENOMAS PITUITARY"
"MALE REPRODUCTIVE SYSTEM NEOPLASM","4","0.093495059365127","0.659348749067541","26.67","brca2, chek2, igf2b, mdm2","MALFORMATION MALE REPRODUCTIVE TRACT; INDUCTION MALE REPRODUCTIVE TRACT; MALFORMED MALE REPRODUCTIVE TRACT"
"GO:0007269","3","0.0936940979890981","0.491283897787394","12","adora2aa, P2RY1, slc18a2","OVERACTIVATION NEURONOTRANSMITTER RELEASE"
"GO:0046562","5","0.148675341632146","0.478762154802979","18.52","akr1a1b, dldh, eno1a, pck2, pgm1","DECREASED GLUCOSE OXIDASE ENZYME ACTIVITY"
"LOCOMOTORY BEHAVIOR","3","0.149703719415149","0.564545229055467","4.84","adora2aa, ncor1, slc18a2","REDUCED SWIMMING SPEED; REDUCED SWIMMING PERFORMANCE"
"HYPERACTIVITY","5","0.164820171857671","0.470525335809611","10","fgf8a, fgfr1a, gamt, igf2b, odc1","INDUCTION ATAXIA PARALYSIS OR HYPERACTIVITY; INCREASED ATAXIA PARALYSIS OR HYPERACTIVITY; N/A ATAXIA PARALYSIS OR HYPERACTIVITY"
"IMMUNOLOGIC HYPERSENSITIVITY","7","0.200834103171783","0.339794727101699","30.43","casp8, fgf8a, fgfr1a, gtf2h5, igf2b, nfkb2, odc1","INCREASE ALLERGIC RESPIRATORY HYPERSENSITIVITY RESPONSE"
"TRIGLYCERIDE METABOLIC PROCESS","5","0.315928506024775","0.488521538489421","31.25","fabp3, gk5, lpgat1, pck2, sirt1","ACCUMULATION TRIGLYCERIDE"
"ABNORMALITY OF THE BLADDER","7","0.315929327762598","0.294700606133676","13.46","cdk6, dnmt1, igf2b, rarab, rarga, smad3a, tbp","REDUCED POSTERIOR SWIM BLADDER INFLATION; REDUCED ANTERIOR SWIM BLADDER INFLATION; INCREASE URINARY BLADDER CALCULI"
"GO:0005184","2","0.316984025923792","0.018736874350647","66.67","adcyap1b, nppa","SP SUBSTANCE P RELEASE LOCAL INCREASE OF SP"
"GO:0001525","5","0.321115485522008","0.311884144849042","13.51","hdac3, nfkb2, rab5c, rps29, vegfc","REDUCTION ANGIOGENESIS; INCREASED ANGIOGENESIS"
"BRADYCARDIA","2","0.330123201415481","0.0312092983195983","33.33","kcnh2a, nppa","INCREASED ATRIOVENTRICULAR BLOCK AND BRADYCARDIA"
"GO:0016209","2","0.330222876426266","0.676424141796413","18.18","gstk1, mgst3","OXIDATION GLUTATHIONE"
"GO:0030545","8","0.362731360638644","0.236426781436103","13.56","adcyap1b, bmp1a, fgf8a, igf2b, mif, nppa, tgfb3, vegfc","DESENSITIZATION NICOTINIC ACETYLCHOLINE RECEPTOR"
"GO:0042446","6","0.394298197147251","0.366746424916278","21.43","arnt, cyp11a1, hif1ab, hsd17b2, nfkb1, tspo","INCREASE LUTEINIZING HORMONE LH; REPRESSED EXPRESSION OF STEROIDOGENIC ENZYMES"
"GO:0005216","3","0.399357367527688","0.0406731594120298","12.5","gria3b, grik1a, kcnh2a","IMPAIRED ION CHANNELS"
"SOMATIC MUTATION","8","0.399799048689038","0.252790960858446","9.52","brca2, casp8, chek2, erbb2, fgfr1a, foxo1b, igf2b, rad54l","INCREASED INDUCED MUTATIONS IN CRITICAL GENES; INCREASE MUTATIONS; INCREASE MUTATIONS IN CRITICAL GENES"
"GO:0004970","2","0.417480524900933","0.0829886489627288","33.33","gria3b, grik1a","BINDING OF AGONIST IONOTROPIC GLUTAMATE RECEPTORS"
"RESPONSE TO NITRIC OXIDE","2","0.428839898027444","0.871281147745113","28.57","foxo1b, txn","DECREASED NITRIC OXIDE"
"ABNORMALITY OF REPRODUCTIVE SYSTEM PHYSIOLOGY","13","0.486998913065944","0.158529143601012","12.62","brca2, cyp11a1, ddb2, eif2b1, fgf8a, fgfr1a, gtf2h5, igf2b, mdm2, pmm2, polr3h, raf1b, rps4x","N/A IMPAIRMENT OF REPRODUCTIVE CAPACITY"
"LIPID ACCUMULATION IN HEPATOCYTES","6","0.535934516691103","0.377620656195083","18.75","adka, atp6ap1b, iars, pck2, pgm1, pmm2","INCREASE PRENEOPLASTIC FOCI HEPATOCYTES"
"DECREASED FERTILITY","7","0.539406695529014","0.291592820908129","9.21","brca2, cyp11a1, fgf8a, fgfr1a, gtf2h5, polr3h, raf1b","IMPAIRED FERTILITY; DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY; REDUCTION CUMULATIVE FECUNDITY AND SPAWNING; DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY; DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY; DECREASED TESTOSTERONE"
"GO:0099536","12","0.540316587064596","0.0721578553878219","10.81","ache, adcyap1b, adora1, adora2aa, gria3b, grik1a, nos1, P2RY1, psmc5, rpl22, slc18a2, ywhah","DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN; DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN"
"GO:0004364","3","0.543567718705684","0.342482197849577","60","gstk1, gstt1a, mgst3","DOWN REGULATION GSS AND GSTS GENE"
"APOPTOSIS","6","0.557701070844423","0.387253424501063","10.71","apaf1, casp8, igf2b, jun, mdm2, nfkb1","INCREASED APOPTOSIS ADENOMAS/CARCINOMAS FOLLICULAR CELL"
"GO:1903409","6","0.599809861813114","0.222877199962511","24","cyp1a, nos1, slc18a2, smad3a, trap1, tspo","INCREASE ROS PRODUCTION; PRODUCTION REACTIVE OXYGEN SPECIES"
"GO:0006936","12","0.615437112098921","0.113797284014749","21.82","adora1, calm1b, ednraa, ednrba, eno1a, gamt, kcnh2a, myl6, nos1, nppa, rock1, tnnt2a","REDUCTION ABDOMINAL MUSCLE CONTRACTION; OVERACTIVATION MUSCLE CONTRACTION"
"GO:0044414","10","0.647005462574576","0.148969256127849","25","atp6ap1b, atp6v0ca, atp6v1e1b, atp6v1f, nos1, rab5c, sec61a1, sec61g, tuba8l, tuba8l4","SUPPRESSION IMMUNE SYSTEM"
"CTOME ACTIVATION OF AMPK DOWNSTREAM OF NMDARS","4","0.683565281302431","0.331552477924887","30.77","prkaa1, prkag1, tuba8l, tuba8l4","INHIBITION NMDARS; OVERACTIVATION NMDARS"
"ABNORMAL NEURON MORPHOLOGY","3","0.684103245614569","0.546231037062042","18.75","smn1, tuba8l4, uba1","HYPERPOLARISATION NEURON"
"ABNORMAL CARDIAC TEST","3","0.705595646877936","0.191023610062058","23.08","gata6, kcnh2a, nppa","INCREASED CARDIAC ARRTHYMIA"
"JNK CASCADE","5","0.717179964377619","0.131434612155674","22.73","dusp3a, hdac3, ncor1, nppa, rps27a","ACTIVATION JNK"
"GLYCOLYSIS AND GLUCONEOGENESIS","3","0.767012201059751","0.335430760113168","13.04","dldh, eno1a, mdh1aa","DECREASED PCK1 EXPRESSION CONTROL POINT FOR GLYCOLYSIS/GLUCONEOGENESIS PATHWAY"
"G GLUTATHIONE METABOLISM","4","0.800308337460339","0.225101494611624","50","gstk1, mgst3, odc1, rrm1","DEPLETION GSH"
"GO:0022414","5","0.810234827063186","0.14649134630366","13.89","ahr2, brca2, h2afx, rad54l, ttk","INCREASED REPRODUCTIVE SUCCESS"
"GO:0004872","26","0.830327545591672","0.0482587345492167","10.88","acvr1l, adcyap1b, adora1, adora2aa, avpr1a, CCKAR, ednraa, ednrba, erbb2, fgf8a, fgfr1a, gabbr1b, gria3b, grik1a, igf2b, nppa, opn4b, opn5, P2RY1, pparda, rarab, rarga, rxrba, tgfb3, thraa, vegfc","ACTIVATION PXR/SXR"
"G TGF BETA SIGNALING PATHWAY","9","0.832576658417859","0.186207194448916","13.24","acvr1l, id1, ppp2cb, rbx1, rock1, skp1, smad3a, tfdp1a, tgfb3","ACTIVATION TGF-BETA PATHWAY; UP REGULATION TGFBETA1 EXPRESSION"
"ABNORMALITY OF THE LIVER","27","0.83958123607353","0.0595258677723494","3.6","ache, adka, agla, atp6ap1b, brca2, btk, casp8, cox5aa, dhfr, dldh, gata6, hyou1, iars, igf2b, mif, ndufs4, nfkb1, nfkb2, pck2, pgm1, pigs, pmm2, raf1b, rnaseh2b, srp54, tnnt2a, whsc1","INCREASED INDUCTION OF UDPGT'S IN LIVER; INCREASED LIVER STEATOSIS; INCREASED LIVER STEATOSIS; N/A HEPATOTOXICITY HEPATOPATHY INCLUDING A CONSTELLATION OF OBSERVABLE EFFECTS; INDUCTION SUSTAINED HEPATOTOXICITY"
"SYNAPTIC TRANSMISSION GLUTAMATERGIC","3","0.869189280604822","0.181343545135093","23.08","adcyap1b, adora1, adora2aa","REDUCED PRESYNAPTIC RELEASE OF GLUTAMATE"
"RESPONSE TO REACTIVE OXYGEN SPECIES","13","0.890949385899739","0.116873628699506","23.21","btk, dhfr, foxo1b, hif1ab, hsf1, jun, nfe2l2a, nos1, ppp2cb, prkaa1, sirt1, trap1, txn","INCREASED REACTIVE OXYGEN SPECIES"
"GO:0051899","5","0.892777322644558","0.0757909732157164","23.81","adora2aa, jun, kcnh2a, tspo, ywhah","OCCURRENCE A PAROXYSMAL DEPOLARIZING SHIFT; PROLONGED DEPOLARIZATION OF NEURONAL MEMBRANE"
"REGULATION OF POTASSIUM ION TRANSPORT","5","0.902956263654607","0.119248821169354","31.25","adcyap1b, adora1, kcnh2a, nos1, nppa","INHIBITION ETHER-A-GO-GO ERG VOLTAGE-GATED POTASSIUM CHANNEL"
"ABNORMAL LIVER MORPHOLOGY","22","0.905811756696838","0.0739681697343396","18.49","adka, agla, atp6ap1b, brca2, btk, casp8, cox5aa, dhfr, dldh, hyou1, iars, igf2b, mif, ndufs4, pck2, pgm1, pigs, pmm2, raf1b, rnaseh2b, srp54, tnnt2a","INDUCTION LIVER “DYSFUNCTIONAL” CHANGES BY CGA 330050; INFLAMMATION LIVER; N/A LIVER FIBROSIS; INCREASE RBC CONGESTION IN LIVER; INCREASE LIVER AND SPLENIC HEMOSIDEROSIS; REDUCTION VITELLOGENIN SYNTHESIS IN LIVER; INCREASE VITELLOGENIN SYNTHESIS IN LIVER; FORMATION LIVER FIBROSIS; FORMATION LIVER TUMOR"
"ABNORMALITY OF THE ABDOMINAL ORGANS","32","0.920589271892373","0.0468148931157895","18.93","ache, adka, agla, atp6ap1b, brca2, btk, casp8, chek2, cox5aa, dhfr, dldh, gata6, hyou1, iars, igf2b, mdm2, mif, ndufs4, nfkb1, nfkb2, pck2, pgm1, pigs, pmm2, raf1b, rarab, rarga, rnaseh2b, srp54, tnnt2a, umps, whsc1","IMPAIRED DEVELOPMENT OF REPRODUCTIVE ORGANS"
"GO:0019932","11","0.921302145706354","0.131311343514318","18.03","adcyap1b, adora2aa, avpr1a, btk, calm1b, ednrba, ndufs4, nme2b.2, nos1, nppa, prkaa1","INCREASED SECOND MESSENGER PRODUCTION"
"NUCLEAR RECEPTORS","4","0.961485939622434","0.200911324875686","7.69","rarab, rarga, rxrba, thraa","ACTIVATION HEPATIC NUCLEAR RECEPTORS"
"GO:0019882","11","0.982870900747208","0.112873284282456","18.64","ap1s2, ap2m1a, psma2, psmb3, psmb6, psmb7, psmc5, psmc6, psmd1, psmd10, psmd5","GENERATION OF NOVEL EPITOPES  ANTIGEN PRESENTATION"
"PYRUVATE METABOLIC PROCESS","14","1.02851009250528","0.10795463896518","25","arnt, dldh, eno1a, hif1ab, ncor1, nup188, nup37, nup88, ogdhb, pck2, pgm1, pom121, prkaa1, prkag1","INHIBITION 4-HYDROXYPHENYL-PYRUVATE DIOXYGENASE HPPD ENZYME"
"GO:0001816","22","1.04190737053212","0.0569076447732417","18.33","adcyap1b, arnt, btk, casp8, fgfr1a, gata6, hif1ab, hsf1, lyn, mif, nfkb1, nfkb2, polr2eb, polr3d, polr3h, rps6ka5, sirt1, smad3a, tgfb3, tmsb4x, tspo, uba1","NON-NEURONAL PRODUCTION OF TNF EPITHELIAL IRRITATION; PRODUCTION OF NERVE GROWTH FACTOR  EPITHELIAL IRRITATION; NON-NEURONAL PRODUCTION OF IL-8/CXCL1 EPITHELIAL IRRITATION"
"GO:0007051","5","1.05252569586937","0.133451599623907","18.52","chek2, hdac3, kpnb1, ncor1, ttk","DISORGANIZATION SPINDLE"
"GO:0046903","51","1.06588558433995","0.0246439199823504","22.08","ache, actn1, adcyap1b, adora1, adora2aa, agla, apaf1, arpc5b, atp5j, atp6ap1b, atp6v0ca, avpr1a, btk, calm1b, CCKAR, cfd, CKAP4, ednrba, fgfr1a, hif1ab, igf2b, kpnb1, lyn, mif, mvp, ncoa1, ndufc2, nfkb1, nme2b.2, nppa, P2RY1, per2, pgm1, pparda, psma2, psmb7, psmd1, ptgesl, rab5c, raf1b, ralaa, rock1, SERP1, slc18a2, slc25a5, tcf7l2, tgfb3, tmsb4x, tuba8l4, umps, vegfc","SUPPRESSION VLDL SECRETION; INCREASE MUCIN PRODUCTION; INCREASED SECRETION OF LOCAL GROWTH FACTORS"
"GO:0050663","3","1.06698555354073","0.168428294556705","10","lyn, mif, tmsb4x","RELEASE CYTOKINE"
"GO:0007612","3","1.10699891383784","0.080734129676832","12.5","ache, hif1ab, jun","IMPAIRMENT LEARNING AND MEMORY"
"GO:0042447","2","1.1203118448622","0.151879585129295","50","ache, ywhah","INCREASED T4/T3 CATABOLISM"
"GO:0007059","6","1.1425613462791","0.11933637980877","13.64","cdc27, kpnb1, nup37, sirt2, slc25a5, ttk","INCREASED CHROMOSOME MISSEGGREGATION"
"GO:0005515","11","1.1480281885984","0.150664797829819","23.4","acvr1l, arntl1b, arntl2, bmp1a, eif1axb, gata5, rab5c, smad3a, tbx5a, tcf7l1a, thraa","BINDING SH-/SELEN-PROTEINS; COVALENT BINDING PROTEIN"
"GO:2000193","2","1.1764048650717","0.0870323441633454","66.67","fabp3, mif","INCREASE FA INFLUX"
"GO:0001775","38","1.17743172106302","0.0322458920857557","19.39","adora2aa, agla, apaf1, arpc5b, atp6v0ca, btk, casp8, cdk6, cfd, CKAP4, dusp3a, erbb2, igf2b, ilk, jun, kpnb1, lyn, mif, mvp, ndufc2, nfkb1, nfkb2, nme2b.2, nppa, onecut1, P2RY1, pgm1, psma2, psmb7, psmd1, ptgesl, rab5c, raf1b, rock1, rpl22, smad3a, tcf7, whsc1","ACTIVATION DENDRITIC CELLS"
"HEART DEVELOPMENT","20","1.19880696275592","0.062918917434952","15.87","acvr1l, casp8, ednraa, erbb2, fgf8a, foxc1a, gata5, gata6, hif1ab, nos1, nppa, raf1b, rarab, rarga, rock1, smad3a, tbx5a, tnnt2a, vegfc, whsc1","ALTERED LARVAL DEVELOPMENT; IMPAIRED DEVELOPMENT"
"DECREASED BODY WEIGHT","49","1.21362954203519","0.0255948123684944","21.68","aco2, acvr1l, adka, atp6v1e1b, bmp1a, brca2, btk, casp8, chek2, cox5aa, cyp11a1, ddb2, dldh, ednrba, fgf8a, fgfr1a, gata6, gria3b, iars, igf2b, krt97, mcm5, ndufa12, ndufa2, ndufb8, ndufs4, nfe2l2a, nfkb1, nfkb2, nos1, nup188, orc1, plaa, pmm2, pomp, rarab, rarga, rpl31, rps10, rps15a, rps19, rps24, rps26l, rps29, srp54, tgfb3, uba1, umps, whsc1","DECREASED BODY WEIGHT"
"GO:0006898","3","1.22229342823939","0.143449945520619","7.89","ache, ap2m1a, hyou1","REDUCTION VITELLOGENIN ACCUMULATION INTO OOCYTES AND OOCYTE GROWTH/DEVELOPMENT; INCREASED LDL UPTAKE"
"GO:0006954","20","1.24171705433053","0.0466735740866895","17.09","acvr1l, adcyap1b, adora1, adora2aa, btk, ednrba, hif1ab, jun, lyn, mif, nfe2l2a, nfkb1, nfkb2, nppa, plaa, pparda, rps19, rps6ka5, smad3a, tmsb4x","INCREASE INFLAMMATION; INCREASE INFLAMMATION CORNEAL CELLS; INFILTRATION INFLAMMATORY CELLS; INCREASED INFLAMMATION; CHRONIC COUGH RESPIRATORY IRRITABILITY"
"GO:0007249","7","1.24217555566885","0.212840358412976","16.28","btk, casp8, nfkb1, nfkb2, rock1, rps27a, sirt1","INHIBITION NUCLEAR FACTOR KAPPA B NF-KB"
"ELEVATED RED CELL ADENOSINE DEAMINASE LEVEL","7","1.25939746005673","0.0966527888138208","38.89","rpl31, rps10, rps15a, rps19, rps24, rps26l, rps29","INCREASED CYCLIC ADENOSINE MONOPHOSPHATE"
"PURE RED CELL APLASIA","7","1.25939746005673","0.0966527888138208","35","rpl31, rps10, rps15a, rps19, rps24, rps26l, rps29","N/A METHEMOGLOBINEMIA DECREASED HEMOGLOBIN HEMATOCRIT RED BLOOD CELL NUMBER"
"GO:1903009","8","1.31158730949769","0.0657966471657659","23.53","pomp, psma2, psmb3, psmb6, psmb7, psmc5, psmc6, psmd1","DECREASE GTPCH-1"
"GO:0072358","22","1.31475441294862","0.0565181033567755","19.82","acvr1l, dnmt1, e2f8, ednraa, erbb2, fgf8a, fgfr1a, foxc1a, foxo1b, gata6, hif1ab, hoxa1a, id1, jun, mdm2, nfe2l2a, pak4, rock1, sirt1, tbx5a, tcf7l2, vegfc","ALTERED CARDIOVASCULAR DEVELOPMENT/FUNCTION"
"GO:0009790","38","1.31808159538392","0.0339403862677473","22.49","acvr1l, apaf1, arnt, brca2, brk1, casp8, dldh, dnmt1, e2f8, ednraa, fgf8a, fgfr1a, foxc1a, gata6, hif1ab, hoxa1a, hsd17b2, hsf1, igf2b, kif1bp, ncoa1, ndufa2, nfe2l2a, ralaa, rarab, rarga, rnaseh2b, rock1, rpl38, rrp7a, sf3b6, smad3a, tbx5a, tcf7, tfap2a, tgfb3, vegfc, xab2","DEFECT OF EMBRYOGENESIS"
"PANCREATIC HYPOPLASIA","2","1.3338788038521","0.270962760480556","28.57","gata6, srp54","INCREASED PANCREATIC ACINAR TUMORS"
"GO:0003707","5","1.37040086685042","0.155282656978284","15.62","pparda, rarab, rarga, rxrba, thraa","REDUCED MATURATION INDUCING STEROID RECEPTOR SIGNALLING OOCYTE"
"GO:0060291","2","1.39605935484352","0.290621188869329","14.29","adora1, adora2aa","DECREASED LONG-TERM POTENTIATION LTP"
"GO:0040011","43","1.43875937129913","0.0242627422138513","18.94","actn1, acvr1l, adora1, adora2aa, arpc5b, bambia, brk1, CCKAR, cdk6, dusp3a, ednrba, erbb2, fgf8a, fgfr1a, foxc1a, hif1ab, id1, ilk, jun, lyn, lypla2, mdm2, mif, mmp28, nfe2l2a, onecut1, P2RY1, pak4, plaa, pparda, raf1b, ralaa, rock1, rpl24, rps19, rps6ka5, sirt1, smad3a, sox1b, tbx5a, tmsb4x, tspo, vegfc","INCREASED LOCOMOTION; INCREASED MUSCULAR WAVES IN FOOT; DECREASED LOCOMOTION"
"GO:1903008","2","1.45099590739323","0.266628184026241","15.38","hif1ab, tspo","DISRUPTION LYSOSOME"
"GLUTATHIONE METABOLIC PROCESS","4","1.50347088063231","0.286010039116959","40","gstk1, gstt1a, nfe2l2a, ptgesl","GLUTATHIONE SYNTHESIS; GLUTATHIONE HOMEOSTASIS"
"GO:0005102","40","1.50842144506934","0.0252585783589048","19.23","actn1, adcyap1b, adora1, adora2aa, ap2m1a, arnt, avpr1a, bambia, bmp1a, casp8, cdk7, dusp3a, ednrba, erbb2, fgf8a, fgfr1a, hif1ab, igf2b, ilk, krt97, lyn, mdm2, mif, ncoa1, ncor1, nppa, P2RY1, psmc5, ralaa, rarab, rarga, rqcd1, sirt1, smad3a, tbp, tcf7l2, tgfb3, trap1, vegfc, ywhah","DECREASED TESTOSTERONE BINDING TO ANDROGEN RECEPTOR HYPOTHALAMUS"
"MORTALITY AGING","4","1.54100693160294","0.112311509102717","15.38","cox5aa, hyou1, ndufa2, ogdhb","REDUCED FITNESS OR EVEN MORTALITY ACIDOSIS HYPOVOLEMIC SHOCK AND ORGAN DYSFUNCTION; INCREASE MORTALITY; INCREASED MORTALITY"
"ABNORMAL NASAL MORPHOLOGY","36","1.55553209805093","0.0224192265098347","23.23","agla, ap1s2, atp6v1e1b, ednraa, ednrba, fgf8a, fgfr1a, foxc1a, gata5, gata6, hyou1, kif1bp, mdh1aa, mdm2, nansa, nup188, nup88, odc1, pigs, plaa, pmm2, raf1b, rarab, rarga, rpl31, rps10, rps15a, rps19, rps23, rps24, rps26l, rps29, tfap2a, uba1, umps, whsc1","INCREASE SITE OF CONTACT NASAL TUMORS"
"GO:0000003","41","1.55764679376134","0.0243215731472674","20.2","acvr1l, adcyap1b, arnt, avpr1a, brca2, casp8, cyp1a, dldh, e2f8, ednrba, fgf8a, foxc1a, gamt, gata6, h2afx, hif1ab, hsd17b2, hsf1, igf2b, ncoa1, nhp2l1b, nppa, P2RY1, pparda, prkag1, rad54l, rarga, RPL29, rpl39, rqcd1, rrm1, ruvbl1, sirt1, sirt2, tbp, tcf7, tgfb3, thraa, ttk, txn, umps","REDUCED REPRODUCTIVE SUCCESS; REPRODUCTIVE FAILURE"
"ABNORMAL FORM OF THE VERTEBRAL BODIES","10","1.56536815210537","0.0336227794208525","30.3","acvr1l, bmp1a, fgfr1a, kdelr2b, nansa, orc1, pmm2, rps19, srp54, whsc1","CLONAL EXPANSION/CELL PROLIFERATION TO FORM ALTERED HEPATIC FOCI AHF"
"POSITIVE REGULATION OF GENE EXPRESSION","35","1.5803563596093","0.0301423030530016","19.34","adcyap1b, arnt, casp8, dnmt1, eno1a, erbb2, fgf8a, gata5, gata6, hif1ab, id1, krt97, mif, ncor1, nfe2l2a, nfkb1, nfkb2, nos1, polr1e, polr2eb, polr3d, polr3h, prkaa1, prkag1, rock1, rpl23, rpl30, rps4x, rps9, smad3a, tbp, tfap2a, ubr5, whsc1, znrd1","ALTERED GENE EXPRESSION"
"GO:0030163","32","1.5844061448773","0.0313580486305146","20.92","ap2m1a, casp8, cdc27, chek2, cul1a, foxo1b, lypla2, mdm2, nfe2l2a, odc1, plaa, ppp2cb, psma2, psmb3, psmb6, psmb7, psmc5, psmc6, psmd1, psmd10, psmd5, rbx1, rnf7, rock1, rpl23, rps27a, sirt1, sirt2, skp1, smad3a, sumo2b, uba1","INCREASED CATABOLISM OF MUSCLE PROTEIN"
"GO:0006629","41","1.61191113739791","0.03012579585383","19.9","ache, adora1, alg6, avpr1a, bdh2, crls1, cyp11a1, cyp1a, cyp26a1, dldh, eci2, fabp3, fasn, fgfr1a, gata6, gk5, hdac3, hsd17b2, kpnb1, lpgat1, lyn, lypla2, mgst3, mif, ncoa1, ncor1, nfkb1, pck2, per2, pigs, plaa, pparda, prkaa1, prkag1, ptgesl, ptpn13, sirt1, sirt2, thraa, tspo, ywhah","ALTERATION LIPID METABOLISM"
"GO:0019904","21","1.6128685085846","0.0515375091986392","17.07","calm1b, casp8, fgfr1a, hif1ab, hnrnpm, ilk, jun, kcnh2a, kpnb1, lyn, mdm2, nfe2l2a, rfc1, rqcd1, rrm1, sirt1, skp1, tcf7l2, tfdp1a, thraa, ywhah","N/A INTERFERENCES WITH SH-/SELEN-PROTEINS"
"GO:0048870","38","1.6180822577566","0.0289162065343163","19","actn1, acvr1l, adora1, arpc5b, bambia, brk1, CCKAR, cdk6, dusp3a, ednrba, erbb2, fgf8a, fgfr1a, foxc1a, hif1ab, id1, ilk, jun, lyn, mdm2, mif, mmp28, nfe2l2a, onecut1, P2RY1, pak4, plaa, pparda, raf1b, rock1, rps19, sirt1, smad3a, sox1b, tbx5a, tmsb4x, tspo, vegfc","INCREASED MOTILITY"
"ABNORMAL RESPIRATORY SYSTEM MORPHOLOGY","33","1.62136886395402","0.0362123783956149","22.45","atp6v1e1b, brca2, btk, casp8, chek2, ednrba, fgf8a, fgfr1a, foxc1a, gata6, gtf2h5, mdm2, mif, nfe2l2a, nfkb1, nfkb2, nos1, nup88, pmm2, polr3h, raf1b, rarab, rarga, rps15a, smad3a, smn1, srp54, tbx5a, tgfb3, tnnt2a, uba1, umps, whsc1","INCREASED RESPIRATORY DISTRESS/ARREST"
"ABNORMAL LUNG MORPHOLOGY","33","1.62136886395402","0.0362123783956149","25.78","atp6v1e1b, brca2, btk, casp8, chek2, ednrba, fgf8a, fgfr1a, foxc1a, gata6, gtf2h5, mdm2, mif, nfe2l2a, nfkb1, nfkb2, nos1, nup88, pmm2, polr3h, raf1b, rarab, rarga, rps15a, smad3a, smn1, srp54, tbx5a, tgfb3, tnnt2a, uba1, umps, whsc1","INCREASE ADENOMAS/CARCINOMAS BRONCHIOLOALVEOLAR"
"UPPER MOTOR NEURON DYSFUNCTION","27","1.66434123420479","0.0384273456233378","5.7","ap1s2, atp6v1e1b, ddb2, dldh, dnmt1, ednrba, eif2b1, fgf8a, fgfr1a, gamt, gria3b, gtf2h5, iars, mdh1aa, ndufa12, ndufa2, ndufb8, ndufs4, odc1, ogdhb, plaa, qdprb1, rfc1, rnaseh2b, slc18a2, tbp, zgc-92066","DECREASE HISTAMINERGIC NEURON EXCITATION; OCCURRENCE CYTOPLASMIC VACUOLIZATION BILE DUCT CELL; OCCURRENCE CYTOPLASMIC VACUOLIZATION KUPFFER CELL"
"ABNORMALITY OF BLOOD AND BLOOD FORMING TISSUES","43","1.66850680445623","0.0219394474926437","10.64","actn1, acvr1l, alg6, atp6ap1b, atp6v1e1b, brca2, btk, casp8, chek2, dhfr, dldh, gata6, gtf2h5, hyou1, krt97, mdm2, ndufa12, ndufa2, ndufb8, ndufs4, nfkb1, nfkb2, nos1, pgm1, pmm2, pomp, raf1b, rnaseh2b, rpl31, rps10, rps15a, rps19, rps24, rps26l, rps29, sec61a1, smad3a, srp54, tgfb3, thraa, tnnt2a, uba1, umps","DAMAGING RED BLOOD CELLS; HEMOLYSIS"
"LYMPHOCYTE APOPTOTIC PROCESS","2","1.66869372853703","0.309556952255676","25","btk, hif1ab","DECREASED LYMPHOCYTES"
"BREAST CANCER PATHWAY","14","1.68557040400014","0.0746304319834339","12.28","brca2, cdk6, ddb2, erbb2, fgf8a, fgfr1a, jun, ncoa1, nfkb2, raf1b, skp1, tcf7, tcf7l1a, tcf7l2","N/A BREAST CANCER"
"ABNORMALITY OF THE MITOCHONDRION","7","1.71265671414117","0.0463467578417905","5.56","atp5e, cox5aa, dldh, dnmt1, ndufa12, ndufa2, ndufs4","INJURY MITOCHONDRIA; DAMAGING MITOCHONDRIA; N/A MITOCHONDRIAL DYSFUNCTION 1"
"GO:0007568","22","1.72435269878805","0.0410271529631305","25.58","apaf1, brca2, cdk6, chek2, cyp1a, dldh, ednrba, eif2s1b, h2afx, ilk, jun, mapkapk5, mif, nfe2l2a, nfkb2, P2RY1, rad54l, rpn2, SERP1, sirt1, tgfb3, tspo","ACCELERATED AGING"
"GO:0005488","216","1.74471394687939","0.00460748312248203","20.07","aco2, actn1, acvr1l, adcyap1b, ahr2, ap2m1a, apaf1, arnt, arntl1b, arntl2, arpc5b, atp5g3b, avpr1a, bambia, bcl2a, bmp1a, brk1, btk, casp8, cdh10a, cdk6, cdk7, cfl1l, chek2, cltcb, cox17, csnk1da, cul1a, cyp11a1, cyp1a, cyp26a1, cyp2p6, cyp2v1, ddb2, dhfr, dldh, dnmt1, e2f8, eci2, eif1axb, eif2b1, eif2s1b, eno1a, erbb2, fabp3, fasn, fgf8a, fgfr1a, foxc1a, foxk2, foxo1a, foxo1b, gars, gata5, gata6, gk5, gosr2, got2b, gtf2h4, h2afx, hat1, hbbe3, hdac3, hibadhb, hif1ab, hnrnpm, hoxa1a, hsf1, hyou1, iars, id1, igf2b, igfbp2b, ilk, imp4, jak2a, jun, kdelr2b, kpnb1, lsm6, lsm8, lyn, magoh, mapkapk5, mcm5, mdm2, mitfa, mmp28, myl6, ncoa1, ncor1, ndufab1a, nfe2l2a, nfkb1, nfkb2, nfs1, nhp2l1b, nme2b.2, nme7, nos1, nppa, nvl, ogdhb, onecut1, opn5, orc1, oxsr1a, p4ha2, pak2b, pak4, pck2, per2, pgm1, plaa, pole4, polr1e, polr2eb, polr3d, polr3h, pom121, pou2f1b, pparda, prkaa1, prkag1, psmc5, psmc6, ptgesl, ptpn13, ptpn4a, pvalb2, pvalb4, qars, qdprb1, rab5c, rad54l, raf1b, ralaa, rarab, rarga, rbx1, rhoab, rnf7, rock1, rpa3, rpl10a, rpl12, rpl13a, rpl14, rpl19, rpl22, rpl23, rpl24, rpl30, rpl4, rpl6, rpl7, rpl7a, rpl8, rpl9, rps10, rps19, rps2, rps26, rps26l, rps27a, rps29, rps4x, rps6ka5, rps9, rrm1, rrp7a, rsl24d1, ruvbl1, rxrba, sec61a1, sf3b6, sirt1, sirt2, skp1, smad3a, smn1, snrpa, snrpd1, snrpd3l, snrpe, snrpg, sox1b, srp54, srp9, srpr, srprb, sumo2b, tbl3, tbp, tbx5a, tcf7, tcf7l1a, tcf7l1b, tcf7l2, tfap2a, tfap2d, tfdp1a, tgfb3, thoc7, thraa, tmsb4x, tnnt2a, trap1, ttk, tuba8l4, uba1, ubr5, vegfc, whsc1, zgc-55733, zgc-92066","INCREASED BINDING OF CHEMICALS TO 2U SERUM"
"REGULATION OF SODIUM ION TRANSPORT","2","1.76215985992483","0.290971997889765","16.67","nos1, ywhah","INHIBITION SODIUM CHANNEL; MODULATION SODIUM CHANNEL"
"GO:0006120","10","1.78775911167868","0.037594062838962","37.04","dldh, ndufa12, ndufa2, ndufa8, ndufb5, ndufb7, ndufb8, ndufc2, ndufs4, ndufs5","BINDING OF INHIBITOR NADH-UBIQUINONE OXIDOREDUCTASE COMPLEX I"
"ABNORMAL RENAL TUBULE MORPHOLOGY","3","1.79234997605571","0.140780432574492","33.33","foxc1a, ndufb8, pmm2","OCCURRENCE CYSTIC DILATATION RENAL TUBULE; OCCURRENCE CYTOPLASMIC VACUOLIZATION RENAL TUBULE"
"CTOME FOXO MEDIATED TRANSCRIPTION","4","1.79868823740638","0.309177687163619","14.29","foxo1b, sirt1, smad3a, txn","ACTIVATION FOXO"
"GO:0030154","10","1.80222842645703","0.0661369541350437","15.38","foxc1a, kif1bp, lyn, onecut1, pparda, rarab, rarga, rxrba, sox1b, thraa","DIFFERENTIATION OF MYOFIBROBLAST"
"CTOME CELLULAR RESPONSE TO HYPOXIA","13","1.89668009506281","0.0352299761819788","30.23","arnt, hif1ab, psma2, psmb3, psmb6, psmb7, psmc5, psmc6, psmd1, psmd10, psmd5, rbx1, rps27a","N/A HYPOXIA"
"GO:0044703","28","1.95996661695772","0.0204238726941282","24.14","acvr1l, adcyap1b, avpr1a, brca2, cyp1a, dldh, ednrba, foxc1a, gamt, h2afx, hsf1, ncoa1, nhp2l1b, nppa, P2RY1, pparda, prkag1, RPL29, rpl39, ruvbl1, sirt1, sirt2, tbp, tgfb3, thraa, ttk, txn, umps","N/A REPRODUCTIVE FAILURE"
"GO:0048813","3","1.9793434208817","0.15427360814395","23.08","id1, ilk, ywhah","ABERRANT DENDRITIC MORPHOLOGY"
"GO:0048469","7","1.99053390055862","0.0713779567943134","29.17","brca2, btk, dldh, ednrba, fgfr1a, hif1ab, sirt2","INCREASED OOCYTE MATURATION"
"GO:0045333","18","2.04350762420462","0.0262338002081733","25","aco2, cox5aa, cox6c, cyp1a, dldh, hif1ab, mdh1aa, ndufa12, ndufa2, ndufa8, ndufb5, ndufb7, ndufb8, ndufc2, ndufs4, ndufs5, trap1, uqcrq","INCREASE OXIDATIVE METABOLISM"
"GO:0008137","5","2.04936685440218","0.0666240484015894","55.56","ndufa12, ndufb7, ndufb8, ndufc2, ndufs4","INHIBITION NADH-UBIQUINONE OXIDOREDUCTASE COMPLEX I"
"CYTOPLASMIC RIBOSOMAL PROTEINS","39","2.06508875390195","0.0114835478480403","27.08","rpl10a, rpl12, rpl13a, rpl14, rpl19, rpl22, rpl23, rpl23a, rpl24, RPL29, rpl30, rpl31, rpl36a, rpl38, rpl39, rpl4, rpl6, rpl7, rpl7a, rpl8, rpl9, rplp2l, rps10, rps11, rps12, rps15a, rps19, rps2, rps21, rps23, rps24, rps25, rps26l, rps27a, rps29, rps3a, rps4x, rps8a, rps9","OCCURRENCE CYTOPLASMIC VACUOLIZATION PODOCYTE"
"VENTRICULAR ARRHYTHMIA","3","2.10531746772516","0.235356900940671","42.86","kcnh2a, raf1b, tgfb3","OCCURRENCE CARDIAC ARRHYTHMIA"
"REGULATION OF CELL DEATH","53","2.11077737793867","0.0112443910085753","19.78","actn1, acvr1l, adcyap1b, adora1, adora2aa, apaf1, btk, casp8, chek2, dnmt1, ednrba, eif2s1b, eno1a, fgf8a, fgfr1a, foxc1a, foxo1b, gata6, hdac3, hif1ab, hsf1, hyou1, id1, jun, mdm2, mif, ncoa1, nfe2l2a, nfkb1, nme2b.2, nos1, pak4, prkaa1, psmc5, psmd10, qars, raf1b, rarab, rarga, rps27a, rps3a, sirt1, sirt2, slc25a5, smad3a, tcf7l2, tfap2a, tfap2d, tgfb3, thraa, trap1, tspo, txn","N/A CELL INJURY/DEATH"
"GO:0008213","2","2.14683485420255","0.0778589702971181","28.57","dnmt1, whsc1","ALKYLATION PROTEIN"
"GO:0006412","44","2.157362153313","0.00968218810071615","40.74","eif1axb, eif2b1, eif2s1b, faua, gars, iars, qars, rpl10a, rpl12, rpl13a, rpl14, rpl19, rpl22, rpl23, rpl23a, rpl24, RPL29, rpl30, rpl31, rpl36a, rpl38, rpl39, rpl4, rpl6, rpl8, rpl9, rps11, rps12, rps15a, rps17, rps19, rps2, rps21, rps23, rps24, rps26, rps26l, rps27a, rps29, rps3a, rps4x, rps8a, rps9, rsl24d1","ALTERED PROTEIN PRODUCTION"
"GO:0046983","39","2.18499140573252","0.0147239244033189","19.8","ache, actn1, acvr1l, adora1, adora2aa, arnt, arntl2, cdh10a, chek2, clns1a, e2f8, eno1a, erbb2, fasn, fgfr1a, gars, h2afx, hif1ab, hsf1, id1, jun, kcnh2a, ncoa1, nfkb1, nfs1, odc1, P2RY1, pole4, qdprb1, raf1b, rpl7, rps19, rqcd1, smad3a, tfap2a, tfdp1a, tgfb3, ttk, ywhah","DIMERIZATION AHR/ARNT; REDUCED DIMERIZATION ARNT/HIF1-ALPHA"
"ABNORMAL SOCIAL BEHAVIOR","3","2.19138270476786","0.253140300257406","11.54","gria3b, gtf2h5, ndufs4","ABNORMAL FORAGING ACTIVITY AND BEHAVIOR"
"RESPONSE TO ESTRADIOL","4","2.28259854477167","0.181247689738257","13.33","casp8, cyp1a, hsf1, ncoa1","REDUCTION PLASMA 17BETA-ESTRADIOL CONCENTRATIONS"
"GO:0006839","12","2.30850603994213","0.0383623755683301","26.09","atp5e, atp5f1, atp5g3b, atp5h, atp5j, casp8, kif1bp, prkaa1, slc25a5, tfdp1a, tspo, ywhah","REDUCTION CHOLESTEROL TRANSPORT IN MITOCHONDRIA"
"ARYL HYDROCARBON RECEPTOR PATHWAY","5","2.34147161042253","0.123186689137945","10.42","arnt, cyp1a, jun, ncoa1, nfe2l2a","UP REGULATION CYP1A1; ACTIVATION AHR"
"RENAL TUBULAR DYSFUNCTION","3","2.35145071631474","0.146921382232007","11.54","ndufb8, ndufs4, pmm2","INCREASE HYPERPLASIA RENAL TUBULAR CELLS; INCREASE CYTOTOXICITY RENAL TUBULAR CELL; INCREASE ADENOMAS/CARCINOMAS RENAL TUBULAR; OCCURRENCE RENAL PROXIMAL TUBULAR NECROSIS"
"GO:0045444","7","2.44138021116715","0.126853122292818","17.07","foxo1b, per2, pparda, sirt1, sirt2, smad3a, tcf7l2","INCREASED ADIPOGENESIS"
"GO:0001935","6","2.44142930298576","0.0690521681815032","16.67","arnt, fgfr1a, hif1ab, jun, sirt1, vegfc","INCREASED PROLIFERATION ENDOTHELIAL CELLS"
"GO:0004882","7","2.46882101502698","0.0749413343271348","20","casp8, cdk7, jun, mdm2, ncoa1, pou2f1b, ywhah","N/A ANDROGEN RECEPTOR ANTAGONISM; AGONISM ANDROGEN RECEPTOR; DECREASED ANDROGEN RECEPTOR ACTIVITY; ACTIVATION ANDROGEN RECEPTOR"
"GO:0009611","18","2.52050469110025","0.0291558767859252","16.07","ache, adora2aa, cyp1a, dhfr, erbb2, gata5, gata6, hif1ab, ilk, jun, lyn, nfe2l2a, P2RY1, pparda, raf1b, smad3a, tgfb3, tspo","ACCUMULATION DAMAGED MITOCHONDRIAL DNA"
"ABNORMAL OVARIAN MORPHOLOGY","4","2.54006389906696","0.0994838096246621","10.81","fgf8a, fgfr1a, pmm2, polr3h","PROMOTION OVARIAN GRANULAR CELL TUMORS; DECREASED OVARIAN E2; PROMOTION OVARIAN ADENOMAS"
"GO:0016310","26","2.54277559619769","0.0187831299976037","20.8","acvr1l, adka, btk, cdk6, cdk7, chek2, csnk1da, erbb2, fgfr1a, gk5, ilk, jak2a, lyn, mapkapk5, nme2b.2, nme7, pak2b, pak4, prkaa1, prkag1, psmb7, raf1b, rock1, rps6ka5, skp1, ttk","ACTIVATION SP1"
"ELECTRON TRANSPORT CHAIN","17","2.54721761582392","0.0272472666184709","25","akr1a1b, cox5aa, cox6c, cyp1a, dldh, ndufa12, ndufa2, ndufa8, ndufb5, ndufb7, ndufb8, ndufc2, ndufs4, ndufs5, p4ha2, qdprb1, uqcrq","DISRUPTION MITOCHONDRIAL ELECTRON TRANSPORT CHAIN"
"ABNORMALITY OF THE OVARY","8","2.66385280851952","0.0524550195561562","14.04","brca2, chek2, eif2b1, fgf8a, fgfr1a, mdm2, pmm2, polr3h","REDUCED PROSTAGLANDINS OVARY"
"REGULATION OF PROTEOLYSIS","16","2.69395097360788","0.0348853582585562","14.29","adora2aa, apaf1, casp8, eno1a, hsf1, mdm2, nfe2l2a, psmd10, raf1b, rbx1, rock1, rpl23, sirt1, sirt2, smad3a, sumo2b","IMPAIRED PROTEOSTASIS"
"GO:0006281","20","2.75965223249504","0.0192226764740699","23.53","brca2, cdk7, chek2, ddb2, gtf2h4, gtf2h5, h2afx, hsf1, mcm5, polr2eb, rad54l, rbx1, rfc1, rpa3, rps27a, ruvbl1, sirt1, ubr5, whsc1, xab2","N/A INSUFFICIENT OR INCORRECT DNA REPAIR; INCREASED INSUFFICIENT REPAIR OR MIS-REPAIR OF PRO-MUTAGENIC DNA ADDUCTS; OVERWHELMED MITOCHONDRIAL DNA REPAIR MECHANISMS; INCREASED DNA DAMAGE-REPAIR"
"BLADDER CANCER","4","2.77301682815093","0.120116457787319","9.52","erbb2, mdm2, raf1b, rps6ka5","INCREASE CANCER"
"GO:0003158","4","2.78171183040137","0.0810273872034395","16.67","acvr1l, fasn, id1, rock1","IMPAIRMENT ENDOTHELIAL NETWORK"
"GO:0042060","13","2.81688812860567","0.0414597804008442","14.77","adora2aa, erbb2, gata5, gata6, hif1ab, ilk, lyn, nfe2l2a, P2RY1, pparda, raf1b, smad3a, tgfb3","FAILURE IN VASCULAR REPAIR MECHANISMS UNRESOLVED BLOOD LOSS HEMORRHAGE"
"NEURON CELLULAR HOMEOSTASIS","3","2.83356554724366","0.166753484978029","50","adora1, P2RY1, prkaa1","ALTERED NEUROPHYSIOLOGY"
"GO:0005125","3","2.8506281746192","0.145271506476096","12","bmp1a, mif, tgfb3","ACTIVATION INFLAMMATORY CYTOKINES CHEMOKINES CYTOPROTECTIVE GENE PATHWAYS"
"GO:0015908","5","2.85623234977453","0.0766643187132751","22.73","atp5j, fabp3, mif, ncor1, pparda","INCREASED FA INFLUX"
"REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY","3","2.90281768703339","0.201615106246882","37.5","dhfr, hif1ab, nos1","INHIBITION INDUCIBLE NITRIC OXIDE SYNTHASE BY METABOLITE CGA 265307"
"GO:0016055","6","2.91949404318197","0.0599637511675025","26.09","ap2m1a, csnk1da, tcf7, tcf7l1a, tcf7l1b, tcf7l2","ALTERATION WNT PATHWAY"
"INCREASED SUSCEPTIBILITY TO FRACTURES","4","2.96148838745111","0.0335937360622296","11.43","chek2, fgf8a, fgfr1a, kdelr2b","INCREASED DISEASE SUSCEPTIBILITY"
"GO:0003824","10","2.96944372682591","0.0354379131804666","15.38","agla, eci2, got2b, mdh1aa, nansa, nfs1, odc1, qdprb1, rrm1, umps","DECREASED DHB4/HSD17B4; DECREASE INCORPORATION OF ACTIVE IODIDE INTO IODOTYROSINES; INHIBITION PROLYL HYDROXYLASES; INHIBITION UROD; DECREASE AKT/ENOS ACTIVITY; INHIBITION DEIODINASE 2; INHIBITION DEIODINASE 1; INHIBITION IODOTYROSINE DEIODINASE IYD; INHIBITION DEIODINASE 3; INHIBITION DUAL OXIDASE; INDUCTION UPREGULATION OF GLUCURONYLTRANSFERASE ACTIVITY"
"SMOOTH MUSCLE CELL PROLIFERATION","4","2.97095093928692","0.0993769396742341","15.38","dnmt1, jun, tcf7l2, tgfb3","HYPERTROPHY/HYPERPLASIA SMOOTH MUSCLE"
"OXIDATIVE STRESS","3","2.98663131288054","0.268370648245405","12.5","cyp1a, nfe2l2a, nfkb1","PROPAGATION OXIDATIVE STRESS; N/A OXIDATIVE STRESS; INCREASE OXIDATIVE STRESS / ACTIVATION PMK-1 P38 MAPK; INCREASED OXIDATIVE STRESS; INCREASE OXIDATIVE STRESS / ACTIVATION PMK-1 P38 MAPK; INCREASE ENERGETIC DEMANDS AND THEREFORE METABOLIC STRESS; INCREASED ENERGETIC DEMANDS AND THEREFORE METABOLIC STRESS"
"GO:0042311","4","3.00554751187258","0.131380113296262","26.67","adora1, adora2aa, ednrba, nos1","IMPAIRED VASODILATION"
"NCRNAS INVOLVED IN WNT SIGNALING IN HEPATOCELLULAR CARCINOMA","4","3.0120059676023","0.0733948784663427","8.33","jun, tcf7, tcf7l1a, tcf7l2","INCREASE HERITABLE MUTATIONS IN OFFSPRING"
"ABNORMAL HYPOTHALAMUS PHYSIOLOGY","2","3.06711396311548","0.10256458615695","22.22","fgf8a, fgfr1a","REDUCED PROSTAGLANDIN E2 CONCENTRATION HYPOTHALAMUS; DECREASE E2 BLOOD CONCENTRATIONS AT HYPOTHALAMUS"
"HYPOTHALAMIC GONADOTROPIN RELEASING HORMONE DEFICIENCY","2","3.06711396311548","0.10256458615695","50","fgf8a, fgfr1a","REDUCED GONADOTROPIN RELEASING HORMONE HYPOTHALAMUS"
"GO:0050673","15","3.18625841884309","0.0268828510273837","18.29","arnt, brca2, cdk6, ednrba, erbb2, fgfr1a, hif1ab, id1, jun, nme2b.2, pparda, sirt1, smad3a, tcf7l2, vegfc","INCREASE REGENERATIVE CELL PROLIFERATION TUBULAR EPITHELIAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION TERMINAL BRONCHIOLAR EPITHELIAL CELLS"
"PEPTIDYL LYSINE MODIFICATION","18","3.26550165344906","0.0208782148145706","25.35","arnt, brca2, dnmt1, hat1, mdm2, ncoa1, nos1, nup188, nup37, nup88, pom121, prkaa1, rps6ka5, ruvbl1, sirt1, sirt2, sumo2b, whsc1","N/A COVALENT BINDING TO PROTEIN POSSIBLY LYSINE RESIDUE"
"GO:0043542","7","3.37008716469643","0.0576160456925714","20","fgfr1a, hif1ab, id1, nfe2l2a, sirt1, tmsb4x, vegfc","INCREASED MIGRATION ENDOTHELIAL CELLS"
"GO:0006809","2","3.4777919325486","0.082192857808618","66.67","nos1, tnnt2a","DEPLETION NITRIC OXIDE"
"GO:0007588","4","3.508186293067","0.142824427807087","28.57","adora1, adora2aa, avpr1a, ednrba","INCREASE BILIARY EXCRETION TH GLUCURONIDE"
"REGULATION OF WNT SIGNALING PATHWAY","19","3.53640743140467","0.0230042155393726","24.05","arntl1b, bambia, ilk, nfkb1, psma2, psmb3, psmb6, psmb7, psmc5, psmc6, psmd1, psmd10, psmd5, rbx1, ruvbl1, smad3a, tcf7l1a, tcf7l2, ubr5","INHIBITION WNT PATHWAY"
"STEROID HORMONE MEDIATED SIGNALING PATHWAY","7","3.54826372230425","0.0669662713408994","6.86","arntl1b, ncor1, rqcd1, rxrba, sirt1, ubr5, ywhah","DECREASE STEROIDOGENIC ACUTE REGULATORY PROTEIN STAR; DECREASED HSD17B10 EXPRESSION; REDUCED MATURATION INDUCING STEROID PLASMA"
"ABNORMAL CORNEAL EPITHELIUM MORPHOLOGY","4","3.59731597274286","0.0827185624530363","30.77","ddb2, foxc1a, gtf2h5, kif1bp","INCREASED ACCUMULATION OF ALPHA2U MICROGLOBULIN PROXIMAL TUBULAR EPITHELIUM"
"DNA DAMAGE RESPONSE","8","3.71346352865958","0.051735723295902","13.79","apaf1, casp8, cdk6, chek2, ddb2, h2afx, mdm2, rfc1","INCREASED DNA DAMAGE-REPAIR"
"GO:0003714","4","3.83994836333687","0.105990322760282","20","e2f8, hdac3, ncor1, sirt1","STABILIZATION PPAR ALPHA CO-REPRESSOR"
"SQUAMOUS CELL CARCINOMA","3","3.93460258447375","0.116988669151009","30","ddb2, gtf2h5, krt97","INCREASE PAPILLOMAS/CARCINOMAS SQUAMOUS CELLS; INCREASE RESPIRATORY OR SQUAMOUS METAPLASIA; SQUAMOUS METAPLASIA ABERRANT BASAL CELLS"
"CHOLESTASIS","6","4.0294409158158","0.074750567678188","17.14","adka, atp6ap1b, brca2, dhfr, iars, rnaseh2b","INCREASED CHOLESTASIS; CHOLESTASIS PATHOLOGY"
"NEOPLASM OF THE SKIN","5","4.22853387842702","0.0507065669165191","15.15","ddb2, fgfr1a, gtf2h5, krt97, vegfc","SENSITISATION SKIN"
"VASCULAR CALCIFICATION","2","4.26486395785939","0.0335044442030971","40","gata5, rnaseh2b","OSTEOPOROSIS AND VASCULAR CALCIFICATION BONE DETERIORATION"
"GO:0006633","9","4.32410611900297","0.052712149392875","31.03","avpr1a, cyp1a, fasn, lpgat1, mif, prkaa1, prkag1, ptgesl, sirt1","SYNTHESIS DE NOVO FA; INCREASED DE NOVO FA SYNTHESIS; INCREASED DE NOVO FA SYNTHESIS"
"PROLONGED NEONATAL JAUNDICE","2","4.33126124864986","0.0382485631889645","33.33","atp6ap1b, rnaseh2b","PROLONGED ESTRUS"
"ENDOMETRIAL CANCER","8","4.39014972037026","0.0228621879492427","11.76","ddb2, erbb2, fgfr1a, ilk, raf1b, tcf7, tcf7l1a, tcf7l2","INCREASE ENDOMETRIAL ADENOCARCINOMAS"
"REGULATION OF ATPASE ACTIVITY","3","4.46048275865951","0.071877047336245","18.75","gtf2h4, sirt1, tnnt2a","INHIBITION CA++ ATPASE"
"NEGATIVE REGULATION OF FAT CELL PROLIFERATION","2","4.47699674474474","0.0392528686288568","50","per2, tfdp1a","INDUCTION SUSTAINED CELL PROLIFERATION"
"FAS LIGAND FASL PATHWAY AND STRESS INDUCTION OF HEAT SHOCK PROTEINS HSP REGULATION","3","4.58796625857938","0.166873087757337","11.54","apaf1, casp8, jun","ACTIVATION FAS; UP REGULATION FAS"
"GO:0006635","3","4.59594993311933","0.0538942012303347","15","bdh2, eci2, pparda","DECREASED PEROXISOMAL FATTY ACID BETA OXIDATION OF FATTY ACIDS; DECREASED MITOCHONDRIAL FATTY ACID BETA OXIDATION; DECREASED MITOCHONDRIAL FATTY ACID BETA-OXIDATION; INHIBITION MITOCHONDRIAL FATTY ACID BETA-OXIDATION"
"REGULATION OF PH","5","5.47383543682278","0.0518739385866344","35.71","atp6ap1b, atp6v1e1b, atp6v1f, avpr1a, ednrba","DECREASE INTRACELLULAR PH"
"GO:0006636","4","5.52790610579378","0.0925988176074135","33.33","avpr1a, mif, ptgesl, sirt1","UP REGULATION UNSATURATED FATTY ACID"
"GO:0070265","2","5.63059274406366","0.149778463815475","18.18","casp8, tspo","INCREASE TISSUE DEGENERATION NECROSIS & ATROPHY; INCREASED ONCOTIC NECROSIS"
"TISSUE ISCHEMIA","3","6.14927860259191","0.0815496773042171","20","gata6, smad3a, tgfb3","OCCURRENCE RENAL ISCHEMIA"
"GO:0035357","2","6.31558627449789","0.0386876343604739","66.67","actn1, sirt1","ACTIVATION LXR ALPHA; DECREASED PPAR-ALPHA ACTIVATION; DECREASED PPAR-BETA ACTIVATION; DECREASED PPAR-GAMMA ACTIVATION; INHIBITION PPAR ALPHA; ACTIVATION OF SPECIFIC NUCLEAR RECEPTORS PPAR-GAMMA ACTIVATION; INCREASED PPAR-ALPHA ACTIVATION"
"GO:1904019","4","6.38195740176091","0.0414551380026269","18.18","eif2s1b, nfe2l2a, pak4, tcf7l2","DECREASE APOPTOSIS OF CILIATED EPITHELIAL CELLS"
"LIPID METABOLISM PATHWAY","3","6.4072105182557","0.0513393205664237","25","fasn, prkaa1, prkag1","DAMAGE LIPID BILAYER"
"NRF2 PATHWAY","4","6.46925334023775","0.0571955461260672","10","mgst3, nfe2l2a, txn, zgc-92066","ACTIVATION NRF2"
"GO:0032964","2","7.16569253704086","0.0726847767259782","20","pparda, tgfb3","ACCUMULATION COLLAGEN; EXPRESSION OF COLLAGEN"
"GO:0006915","3","7.53861766805607","0.0424911741729199","9.68","apaf1, bcl2a, casp8","CHANGES/INHIBITION CELLULAR HOMEOSTASIS AND APOPTOSIS; DECREASED APOPTOSIS EPITHELIAL CELLS; INCREASED APOPTOSIS DECREASED LEYDIG CELLS"
"GO:0019098","3","8.09685139352832","0.0266890922377694","33.33","avpr1a, ncoa1, thraa","ALTERED REPRODUCTIVE BEHAVIOUR; REDUCED BROOD CARE"
"MATING BEHAVIOR","3","8.09685139352832","0.0266890922377694","33.33","avpr1a, ncoa1, thraa","REDUCED ABILITY TO ATTRACT SPAWNING MATES"
"REPRODUCTIVE BEHAVIOR","3","8.09685139352832","0.0266890922377694","30","avpr1a, ncoa1, thraa","REDUCED SPAWNING BEHAVIOR"
"GO:0042698","3","8.51870172427492","0.0219735824907859","13.64","ncoa1, sirt1, tgfb3","IRREGULARITIES OVARIAN CYCLE"
"BILE ACID AND BILE SALT TRANSPORT","2","8.6163384327492","0.0301377898102783","40","ncoa1, prkaa1","INHIBITION BILE SALT EXPORT PUMP ABCB11"
"CTOME ACTIVATION OF GENE EXPRESSION BY SREBF SREBP","2","8.6735540639422","0.0281053237842315","16.67","fasn, ncoa1","UP REGULATION SREBF2"
